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Abstract
Hand, foot and mouth disease (HFMD) is a childhood illness frequently caused by genotypes belonging to the enterovirus A species,
including coxsackievirus (CV)-A16 and enterovirus (EV)-71. Between 2010 and 2012, several outbreaks and sporadic cases of HFMD
occurred in different regions of Spain. The objective of the present study was to describe the enterovirus epidemiology associated with
HFMD in the country. A total of 80 patients with HFMD or atypical rash were included. Detection and typing of the enteroviruses were
performed directly in clinical samples using molecular methods. Enteroviruses were detected in 53 of the patients (66%). CV-A6 was the
most frequent genotype, followed by CV-A16 and EV-71, but other minority types were also identiﬁed. Interestingly, during almost all of
2010, CV-A16 was the only causative agent of HFMD but by the end of the year and during 2011, CV-A6 became predominant, while
CV-A16 was not detected. In 2012, however, both CV-A6 and CV-A16 circulated. EV-71 was associated with HFMD symptoms only in
three cases during 2012. All Spanish CV-A6 sequences segregated into one major genetic cluster together with other European and Asian
strains isolated between 2008 and 2011, most forming a particular clade. Spanish EV-71 strains belonged to subgenogroup C2, as did most of
the European sequences circulated. In conclusion, the recent increase of HFMD cases in Spain and other European countries has been due
to a larger incidence of circulating species A enteroviruses, mainly CV-A6 and CV-A16, and the emergence of new genetic variants of these
viruses.
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Introduction
Hand, foot and mouth disease (HFMD) is a childhood illness
characterized by fever and vesicular lesions on the palms of the
hands, soles of the feet, oral mucosa and tongue. The major
causative agents of HFMD are enteroviruses (EVs), in
particular the serotypes belonging to the A species (EV-A)
[1]. Two types, Coxsackievirus A16 (CV-A16) and enterovirus
71 (EV-71), are involved in most cases of HFMD [2,3], but
other EV-A types and some echoviruses have also been
associated with this pathology [4,5].
Although HFMD is classically a mild disease, large outbreaks
in the Asia-Paciﬁc region have been described since 1997, with
a high incidence of fatal cardiopulmonary and neurological
complications, particularly when the causative virus is EV-71
[6–9]. Currently, HFMD is considered endemic and is an
important public health issue in much of the region. In Europe
and North America, it is not a notiﬁable disease but
epidemiological studies of outbreaks caused by different
EV-A types (CV-A16, CV-A10 and CV-A6) have been
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described in recent years [10–14]. EV-71 has also been
detected in several European countries and the USA and,
although rare, infections with fatal outcome have been
reported [15–18].
Onychomadesis or nail shedding is a disorder in children
newly recognized as a complication in the course of HFMD.
Onychomadesis often occurs weeks after initial symptom
onset and was ﬁrst reported in 2000 in ﬁve North American
children [19]. Subsequent studies established a clear link for
these diseases [20,21]. Between the summer of 2008 and early
2009, HFMD outbreaks, followed by onychomadesis and
associated with different EV types, were ﬁrst described in
various Spanish regions [22–25].
During the last 25 years in Spain, an EV surveillance system
has provided considerable data on the types circulating in
association with different pathologies, mainly with aseptic
meningitis [26,27]. Since 2010, however, the Spanish National
Centre for Microbiology (CNM) has increasingly received more
samples from local outbreaks and sporadic cases of HFMD that
occurred in different regions, both for virological diagnosis and/
or type identiﬁcation. The aim of the current study was to
investigate the involvement of the different EV types associated
with the HFMD cases in Spain from 2010 to 2012.
Materials and Methods
Patients and clinical samples
From January 2010 to December 2012, the CNM in Madrid
received 80 clinical samples from patients with signs and
symptoms of HFMD (N = 60) or with fever and atypical rash
(N = 20) from 16 different hospitals in 12 regions of the
country. In 2010 a total of 11 cases were received, 24 were
received in 2011, and in 2012 that number was increased to 45
cases. Of the 80 cases included in the study, 54 were sporadic
and 26 were from six local outbreaks: in Mallorca, June 2010;
in Vigo, September 2011; in Madrid, November 2011 and
March 2012; in Gran Canaria (Canary Islands), May 2012; and
in Caceres, November 2012.
Each specimen was sent with a standardized form with
recorded information on patient demographics (age, sex),
clinical diagnosis (HFMD, onychomadesis after HFMD, rash/
exanthema or febrile syndrome) and date of sample collection.
The mean age of the patients was 13.7 years (ranging from
11 days to 34 years). Clinical specimens were 28 throat swabs
(35%), 21 (26%) stools, 17 (21%) vesicular swabs and 14 (18%)
sera. Onychomadesis occurred in 16 (27%) sporadic cases
after HFMD. In them, clinical samples were collected during
onychomadesis, at 25.6 days (range 12–42 days) after the
acute HFMD phase.
Enterovirus detection and genotyping
EVs had been detected directly in clinical samples by RT-PCR
of the 5′-untranslated region (UTR) of the viral genome as
described elsewhere [26] and carried out in the hospital of
origin or in the Viral Detection Unit of the CNM.
EV typing was performed in the Enterovirus Unit of the
CNM. Samples positive for the 5′-UTR PCR were subjected
to a species EV-A, B and C speciﬁc RT-nested PCR in the
3′-VP1 region as previously reported [28]. Ampliﬁed DNA
was directly sequenced using a BigDye Terminator kit
(Applied Biosystems, Foster City, CA, USA) and both inner
PCR primers.
Phylogenetic analyses
Type identiﬁcation was determined by phylogenetic compar-
ison of EV-A sequences obtained with the prototype strains.
To study the relationships between Spanish strains and those
circulating in other countries, additional phylogenetic analyses
were performed with the nucleotide sequences of Spanish
strains assigned to types CV-A6 and EV-71 and the respective
homologous sequences available from GenBank. Multiple
sequence alignments were performed by the ClustalW
program. Genetic distances were calculated using the maxi-
mum composite likelihood nucleotide distance model, and
statistical signiﬁcance of phylogenies estimated by bootstrap
analysis with 1000 pseudoreplicate datasets. Phylogenetic trees
were constructed using the neighbour-joining method in the
MEGA software 4.0. The sequences obtained in this study have
been deposited in GenBank under accession numbers
KC688834-KC688865.
Results
Clinical and epidemiological data of patients with EV and
non-EV infections
Of the total of 80 clinical samples studied, 53 were positive
for EVs (66%), 43 from patients with HFMD diagnosis and 10
from patients who presented with fever and atypical rash.
There were no statistical differences in mean age, male/female
rate and the distinct syndromes presented between patients
with EV infection and those negative for EVs (data not
shown).
Most of the EV-infected patients (45/53, 85%) were children
(p <0.001), aged between 11 days and 7 years (mean age,
1.7 years), but also young people (8/53, 15%; mean age,
31.4 years) were included. The majority of patients were male
(30/53), but this was not statistically signiﬁcant (p 0.2438).
Shedding of nails occurred after initial HFMD infection in 12
(28%) of the 43 EV-positive patients. Clinical samples were
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taken during onychomadesis symptoms at a mean of 27.1 days
following HFMD.
According to the clinical syndromes presented, those with
onychomadesis after HFMD were younger (1.7  0.9 years)
than those with HFMD alone or atypical rash (8.2  2.3 years,
5.4  10.4 years, respectively), but the differences are not
statistically signiﬁcant.
Regarding the seasonal distribution, HFMD cases mainly
occurred in two annual periods, between March and June and
between September and December, matching the epidemic
peaks of overall EV circulation in the country (Fig. 1).
Prevalent enterovirus genotypes
Fifty (94%) of the 53 EVs detected in HFMD/atypical rash cases
were genotyped. Most EVs (96%) were assigned to a type
within the EV-A species. CV-A6 was predominant, accounting
for 60% of the cases. This was followed by CV-A16, but other
minority A types were also detected. Two cases (4%) were
positive for species B EVs (E-18 and CV-B4).
Through the national EV surveillance system, the CNM
receives a mean of 350 EVs/year for genotyping that are
associated with neurological diseases, mainly meningitis and
febrile syndromes. Most are characterized as echovirus or
coxsackievirus B within EV-B species. During the present
study period, however, EV-A types were also identiﬁed in a
signiﬁcant percentage of patients presenting febrile syndromes
only (6%). It was therefore considered of interest to include
these 12 fever cases in the current molecular epidemiological
study. Hence, in total, CV-A6 was identiﬁed in 34 (55%) of the
62 typed cases, CV-A16 in 11 (18%), EV-71 in 8 (13%), CV-A4
and CV-A8 in two (3% each) and CV-A2, CV-A5 and CV-A14
in one (2% each).
Data on the main genotypes detected according to the
clinical pathologies of patients are included in Table 1. There
are no statistical differences in type variability between the
different syndromes. However, CV-A infections were
predominantly responsible for HFMD cases (p <0.05) while
EV-71 was more frequent in infant febrile syndromes
(p <0.001). Patients infected by EV-71 were signiﬁcantly
younger than those infected by another EV-A (p <0.01).
Finally, the onychomadesis symptoms after HFMD were not
associated with a speciﬁc EV type (p <0.05).
During 2010 (Fig. 2), CV-A16 was the most frequently
detected type, followed by CV-A6. In 2011, CV-A6 was the
predominant type while CV-A16 was not detected. Other
CV-A types were also identiﬁed in the same year. Finally,
during 2012, CV-A16 circulated again, together with CV-A6
and other CV-As. EV-71 was detected during the 3 years, but
mainly during 2012 (6/8, 75%).
Distribution of the three predominant genotypes (CV-A6,
CV-A16 and EV-71) throughout the 3-year study period is
shown in Fig. 1. During almost all of 2010, CV-A16 was the
only type identiﬁed in HFMD cases but in October, this was
replaced by the infrequent CV-A6, which then circulated until
the end of 2011. However, in 2012, a co-circulation of CV-A16
and CV-A6 was observed. With respect to EV-71, this was
associated with HFMD or rash only in three cases from 2012.
The other ﬁve EV-71s were identiﬁed in infant febrile
syndromes.
Phylogenetic analyses
The reconstructed tree in the 3′-half VP1 region showed that
all EV-A sequences clustered with their respective prototype
strain with bootstrap values higher than 95% (data not shown).
Phylogenetic analysis carried out with several Spanish CV-A6
strains (n = 24) and others available in GenBank showed that
the Spanish ones segregated into one major genetic cluster
together with strains detected between 2008 and 2011 in
EV positive samples from all syndromes
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FIG. 1. Distribution of the number of EV-positive samples from all syndromes analysed in the Enterovirus Unit of the CNM between January 2010
and December 2012 (right-axis) and prevalent types from HFMD/rash/fever cases studied (left-axis) by month. CV-A, coxsackievirus A; EV,
enterovirus; EV-B, enterovirus B species.
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Europe (Finland, France and Spain (Valencia)) and Asia (Japan,
China and India). Furthermore, all Spanish strains except for
three (from 2012) formed a particular sub-cluster (Fig. 3a). In
the EV-71 tree (Fig. 3b), the eight Spanish strains detected
between 2010 and 2012 belong to subgenogroup C2.
Discussion
During the last 12 years, large HFMD outbreaks associated
with EV-71 infections and fatal cases in children under 5 years
occurred in the Asia-Paciﬁc region, representing a signiﬁcant
public health threat [6–9]. In several European countries,
including Spain, the number of HFMD cases reported has
increased considerably since 2008 [10,12,14,22–25]. In Europe
HFMD is currently not a reportable disease, unlike in many
Asian countries, so epidemiological data are still scarce.
Nevertheless, the data indicate a recent emergence of
circulating EV-A types in regions outside of the Asia-Paciﬁc
region, as in Europe or North America [10–14,22].
In the present study, 80 cases with HFMD symptoms or
atypical rash, collected between 2010 and 2012 from
different Spanish cities, were analysed. The number of cases
received in 2012 was four-fold higher than in 2010. EV
infections were conﬁrmed in 66% of the cases. Detection
failure may be due to several reasons. In patients with a rash,
other microorganisms or non-infectious agents could be the
cause of the disease. On the other hand, the most
appropriate samples for viral diagnosis of HFMD are vesicular
swabs, but, unfortunately, this type of specimen was available
only in 17 (21%) of the cases. Finally, the viral load in some
samples could be below the detection limit of the technique if
they were taken several days after the acute phase of the
disease. However, the percentage of EV detection described
in the current study is comparable to that reported
previously in Finland, France or North America, which
ranged from 64 to 74% [10,13,14].
The most frequently detected genotype was CV-A6,
followed by CV-A16 and EV-71. Other EV-A types were also
identiﬁed in minor proportions. CV-A10, however, was not
found, although this genotype, together with CV-A6, was one
of the main causative agents of the outbreaks described during
2008–2010 in Finland, France and Spain [10,14,22].
Interestingly, however, although CV-A6 was previously
detected during the outbreak that occurred in Valencia in 2008
[22], this infrequently detected type was ﬁrst identiﬁed in our
laboratory in October 2010. It then replaced CV-A16, the
unique HFMD-associated genotype detected until then [27].
During 2011, CV-A6 was the predominant type causing
HFMD, while CV-A16 was undetectable. In 2012, however,
TABLE 1. Demographic and clinical data associated with the different EV genotypes
Enterovirus genotypes
CV-A6 (n = 34) CV-A16 (n = 11) EV-71 (n = 8) Other EV (n = 9) p value*
Mean age, years 7.9  2.1 4.1  2.9 0.4  0.2 1.1  0.3 0.0030
Male/female ratio 19/15 6/5 7/1 5/4 0.2105
HFMD symptoms 21 (62) 5 (45) 1 (12) 2 (22) 0.0343
HFMD symptoms + onychomadesis 4 (12) 1 (9) 1 (12) 5 (55) 0.0159
Rash + fever 7 (20) 2 (18) 1 (12) 0 0.9810
Infant febrile syndromes 2 (6) 3 (27) 5 (64) 2 (22) 0.0008
Data are mean  standard deviation for age and N (%) of patients for clinical symptoms.
*Signiﬁcant variations between four groups were evaluated using the Student t-test for age and chi-squared test for clinical symptoms. The p value below 0.05 was considered to be
signiﬁcant and appears in bold.
CV-A6 CV-A16 EV-71 other CV-A EV-B no typed EV
2010 20122011
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46%
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FIG. 2. Distribution of EV types associated with HFMD alone, HFMD plus onychomadesis, atypical rash and febrile syndromes by year. CV-A,
coxsackievirus A; EV, enterovirus; EV-B, enterovirus B species.
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CV-A16 re-emerged and both EVs co-circulated during the
ﬁrst 5 months of the year. Again, during the autumn of 2012
CV-A6 predominated (Fig. 1).
Regarding EV-71, this type was associated with HFMD for
the ﬁrst time in 2012. In Spain, the incidence of EV-71 had been
very low and always caused neurological manifestations [27].
Indeed, only 37% of the EV-71 detected in the present study
was associated with rash or HFMD symptoms. Other infants
with EV-71 infections had a clinical presentation only of fever.
Therefore in Spain, although the EV-71 circulation seems to
have increased in recent years, its infection is still associated
more with febrile syndromes in young children than with
HFMD. Phylogenetic analysis showed that all Spanish EV-71s
belonged to subgenogroup C2, like most of the strains
circulating in Europe in recent years, and had been assigned
to subgenogroups C1 and C2 within genogroup C [15–18].
However, the C4 subgenogroup, which was associated with
large outbreaks in China [9], seems not to have spread in Spain
and other European countries.
With respect to clinical outcome, CV-A types can cause
HFMD or atypical rash both in children and young people,
although it is more common in children (p <0.01). However,
onychomadesis after HFMD was restricted to children
between 1 and 4 years. Comparison with the clinical
presentations in previous HFMD outbreaks indicates that
encephalitis and convulsions were reported in ﬁve cases
from Finland in 2008 [10] and in one from Japan [29], while
none of the patients from our series or from others
presented with severe neurological manifestations [11–
14,22–25]. With respect to the emergence after HFMD of
onychomadesis, nail shedding was reported in HFMD cases
from Finland, Spain, Taiwan, North America and Japan
[10,13,21–25,29], but not in those from France or Croatia
[12,14]. Several genotypes (CV-A6, CV-A10, CV-A16 and
CV-B1) were identiﬁed there. In the Spanish study of the
2008 outbreak [22], the authors suggested an association
between the emergence of this complication after HFMD and
detection of a mixed infection (the EV type that causes
HFMD plus CV-B1). In the current study, onychomadesis
was observed in 12 of the EV-positive patients. In 92% of
them, EV was typed, despite the samples having been taken
12–42 days after HFMD. No link between onychomadesis
and a speciﬁc genotype was found because seven different
types were detected. Furthermore, emergence of onycho-
madesis was signiﬁcantly more frequent in cases infected by
EV types other than CV-A6, CV-A16 or EV-71.
Our data agree with previous reports suggesting that
co-circulation of several CV-A types in Europe and the
emergence of genetic variants spreading into new geographical
areas caused the HFMD outbreaks since 2008 in several
countries. With respect to CV-A6, HFMD outbreaks caused
by this type were described in China, Taiwan and Japan in
2005–2011 [8,21,29]. An increase in its prevalence has also
been reported in several European countries since 2008
[10,14]. Recently HFMD outbreaks caused by CV-A6 were
described in the USA [11,13]. Phylogenetic relationships
between available CV-A6 sequences in the 3′-VP1 region
showed that the predominant lineage circulation in Asia and
Europe after 2008 is a genetic variant distinct from that
previously detected in Asia. Hence the increase in circulation
of several EV-As and the emergence of new CV-A types,
mainly CV-A6, has contributed to the increased incidence of
HFMD cases in Spain in recent years. Indeed, a large HFMD
outbreak caused by CV-A6 that occurred in a northern city
during 2011 was very recently reported [30]. Regarding EV-71,
in Spain as in other European countries [15,17,18,27], C2
strains are circulating with a low incidence and only a few cases
are associated with HFMD.
In conclusion, the overall epidemiology of HFMD caused by
EV-A in Europe is similar to that observed in the Asian region,
but the frequency of EV-71 infections is much lower. The
reason for this difference is still unclear. Even so, there is a
need for reinforced surveillance of HFMD to differentiate
benign EV-A genotypes from EV-71 and for better manage-
ment of future outbreaks.
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